Heterogeneity of the CYP2D6 gene among Malays in Malaysia

Journal of Clinical Pharmacy and Therapeutics

Volumn 26, Issue 3, 2001, Pages 205-211

  Teh, L K ^a   Yusoff, R ^a   Hussein, A ^b   Isa, M N ^b   Rahman, A R A ^b   Ismail, Rusli ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Allele frequency; CYP2D6 polymorphism; Ethnic difference; Malaysian Malays

Indexed keywords

CYTOCHROME P450 2D6;

ARTICLE; ASIAN; DRUG METABOLISM; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; POLYMERASE CHAIN REACTION; PREVALENCE; RACE DIFFERENCE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 CYP2D6; DEBRISOQUIN; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALAYSIA; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0034948852     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2001.00347.x     Document Type: Article

References (29)

1. CYP2D6*10 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients
2. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquine and S-mephenytoin
3. Frequency of human CYP2D6 mutant alleles in a normal Chinese population
4. Genetic analysis of the Chinese cytochrome P450D locus: Characterization of variant CYP2D6 gene present in subjects with diminished capacity for debrisoquine hydroxylation
5. Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects
6. The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population
7. Oxidation phenotyping in Chinese and Malay populations
8. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations
9. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population
10. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population
11. CYP2D6 phenotypes among Malays in Malaysia
12. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
13. Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: Possible association with the poor metaboliser phenotype
14. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians
15. A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a Black African population: Association with diminished debrisoquine hydroxylase activity
16. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
17. Detection of the poor metabolizer-associated CYP2D6 (D) gene deletion allele by long PCR technology
18. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population
19. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile
20. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: Role of selection versus drift in world populations
21. Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: Polymorphism in RFLP and DNA sequence of CYP2D6
22. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes
23. Polymorphism of dextromethorphan oxidation in South Indian subjects
24. Genetic polymorphism of CYP2D6 in a Keralite (South India) population [letter]
25. Evidence for the polymorphic oxidation of debrisoquine in the Thai population
26. Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population
27. Debrisoquine/sparteine hydroxylation genotype and phenotype: Analysis of common mutations and alleles of CYP2D6 in a European population
28. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: Characterization of 48 mutations and 53 alleles, their frequencies and evolution
29. The polymorphic 4-hydroxylation of debrisoquine in a Saudi Arab population